| |
| |
|
| Insider
Information: |
Renschler Markus Md |
| Relationship: |
President and CEO, Dir... |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,105,055 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,333,056 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,105,055 |
|
|
| Total
Value |
$3,333,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
VP, Oncology Clinical ... |
2004-11-11 |
1,394 |
2004-11-11 |
0 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
President and CEO, Dir... |
2024-03-04 |
1,103,661 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYT |
Cyteir Therapeutics, Inc. |
President and CEO |
• • – |
2024-03-04 |
4 |
OE |
$1.69 |
$10,654 |
D/D |
6,304 |
1,103,661 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
President and CEO |
• • – |
2024-02-29 |
4 |
OE |
$1.20 |
$24,350 |
D/D |
15,144 |
1,097,357 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
President and CEO |
• • – |
2023-11-20 |
4 |
OE |
$1.20 |
$129,366 |
D/D |
84,637 |
1,073,373 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
President and CEO |
• • – |
2023-11-20 |
4 |
OE |
$1.20 |
$13,697 |
D/D |
8,840 |
1,082,213 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-13 |
4 |
A |
$1.49 |
$7,450 |
D/D |
5,000 |
983,736 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
See RemarksOfficer |
• • – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
841,954 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP, Oncology Clinical Dev. |
• – – |
2004-11-11 |
4 |
OE |
$4.25 |
$182,607 |
D/D |
42,000 |
43,394 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP, Oncology Clinical Dev. |
• – – |
2004-11-11 |
4 |
S |
$11.49 |
$483,190 |
D/D |
(42,000) |
1,394 |
|
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
